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Background: Sickle-cell anaemia (SCA) is the most common inherited haemoglobinopathy affecting the Negroid
race. Renal complications such as enuresis can occur during childhood. Reports show that children and adolescents
with SCA may be at a higher risk of nocturnal enuresis than their counterparts with normal haemoglobin genotype.
Aims: The study aims to determine the prevalence of nocturnal enuresis and possible risk factors among
school-aged children with SCA in a South-east Nigerian city.
Methods: A hospital-based and cross-sectional descriptive study of 70 school-aged children with SCA who met the
study criteria, and 70 age- and sex-matched controls with normal haemoglobin genotype was conducted in the
Paediatric Sickle-cell Anaemia Clinic of the University of Nigeria Teaching Hospital (UNTH) Enugu. Data was subjected
to multivariate analysis using logistic regression model with nocturnal enuresis as the dependent variable and the
possible risk factors as the independent variables.
Results: The prevalence of nocturnal enuresis among the Subjects and the Controls was 31.4 and 21.4 %
respectively (p = 0.180). It was significantly higher among male Subjects (48.7 %) than among male Controls
(23.1 %) [OR (95 % CI) =8.14 (2.12–31.24), p < 0.001]; and among Subjects whose parents had a childhood
history of enuresis [OR (95 %) =10.39 (2.45–44.05), p = 0.002]. The difference in the prevalence of enuresis in
the female cohort was however not significant.
Conclusions: Children with SCA have a tendency to develop nocturnal enuresis when compared to their
non-affected counterparts. Male gender and parental childhood history of nocturnal enuresis are potential
socio-demographic risk factors.
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Sickle-cell anaemia (SCA) is the most common inherited
haemoglobinopathy which affects millions of people in
the Tropics especially sub-Saharan Africa [1], and is also
common among African-Americans [2]. Nigeria ac-
counts for the largest number of cases worldwide with a
prevalence of about 20 per 1000 births [3].
Infarction-related renal complications start from child-
hood [4], and include tubulopathies like impaired ability
to concentrate urine (manifesting as hyposthenuria,* Correspondence: snuwaezuoke@yahoo.com
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(http://creativecommons.org/publicdomain/zepolyuria and enuresis) and abnormalities of urine acidifi-
cation [5–7].
The Diagnostic and Statistical Manual of Mental
Disorders-IV (DSM-IV) criterion defines enuresis as the
repeated voiding of urine into bed or clothes which may
be involuntary or unintentional, the behaviour being
clinically significant if manifested by either a frequency
of voiding twice weekly for at least 3 consecutive
months or the presence of significant distress or impair-
ment in social, academic (occupational) or other import-
ant areas of functioning by a child five years or older
and the behaviour not being due exclusively to the direct
physiological effect of a substance (a diuretic) or adistributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
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seizure disorder) [8].
Several studies in both developed and developing
countries which evaluated the prevalence of enuresis
among children and adolescents with SCA show that
they may be at a higher risk of nocturnal enuresis than
their counterparts with normal haemoglobin genotype
[9–14]. For instance, Akinyanju et al. [12] reported a
high prevalence value of 41.6 % in South-west Nigeria
among paediatric SCA patients compared to 18.5 % in
their counterparts with normal haemoglobin. Among
children with SCA in Congo Brazzaville, other researchers
[9] documented a prevalence value of 50.9 and 16.4 %
among their peers with normal haemoglobin genotype.
However, there appears to be dearth of data on the preva-
lence of enuresis among affected children in the south-
eastern part of Nigeria. Furthermore, abnormalities of
urinalysis such as proteinuria, leucocyturia and haema-
turia have also been noted in other studies conducted in
South-eastern part of the country [15, 16].
The present study was thus conducted to determine
the prevalence of and the risk factors for nocturnal enur-
esis among school-aged children with SCA seen in a
tertiary health facility in Enugu, South-east Nigeria.
Subjects and methods
Study site/design/population
The study was conducted at the University of Nigeria
Teaching Hospital (UNTH) - a major tertiary health fa-
cility located within Enugu metropolis, South-east
Nigeria. It was a descriptive, cross-sectional study in
which 70 children with SCA and their 70 age- and sex-
matched controls were recruited consecutively. The Sub-
jects were drawn from school-aged children attending
the weekly Paediatric Sickle Cell Clinic of the hospital
while the Controls were their classmates with normal
haemoglobin genotype.
Study criteria/sampling method
After obtaining ethical approval from the Health Re-
search and Ethics Committee of the hospital and written
informed consent from the parents/caregivers, the pa-
tients were enrolled following fulfillment of the follow-
ing inclusion criteria: diagnosis of SCA confirmed by
haemoglobin electrophoresis; age of 5 to 11 years; stable
state; clinic attendance for at least 6 months prior to the
study; and primary school attendance within Enugu me-
tropolis. Children who had a history and urine sugar
level suggestive of diabetes mellitus; a history suggestive
of urinary tract infection; a personal history of epilepsy
and; a history of diuretic medication were excluded.
The Controls were recruited from the primary schools
attended by the corresponding Subjects following the in-
formed consent of school authorities and the parents/caregivers. The haemoglobin genotypes of the pupils
selected consecutively from the class register were deter-
mined to confirm their haemoglobin AA status. On the
whole, 70 Subjects with haemoglobin SS and 70 Con-
trols with haemoglobin AA were enrolled for the study.
Data collection
A 26-item proforma consisting of open-ended questions
on demographic data (such as the child’s age, parents’
educational attainment and occupation, as well as family
size) and closed-ended questions on historical evaluation
of enuresis based on the DSM-IV criterion (including
family history of enuresis) was administered by the prin-
cipal investigator (CIE) to the parents/caregivers of the
enrolled Subjects and their class-mate Controls. Another
15-item proforma comprising open-ended questions on
bio-data (child’s age and gender) and closed-ended ques-
tions on past medical history and evaluation for enuresis
was also administered to the Subjects and Controls.
Social classification of the Subjects and the Controls
was determined using the occupation and educational
attainment of their parents or caregivers based on the
method described by Oyedeji. [17]. Class I represents
the upper social class, Classes II and III the middle class
and Classes IV and V the lower class.
Data analysis
Data entry and analysis were conducted using the Statis-
tical Package for Social Sciences (SPSS) version 17.0
software. Descriptive statistics, including frequencies and
percentages were used to summarize the socio-
demographic data. Continuous variables were presented
as means and standard deviation. Means were compared
between continuous variables using 2 tailed Student’s t-
test. The significance of the difference between the fre-
quencies of categorical variables was ascertained using
the Chi square test, or Fisher’s Exact Test as appropriate .
Level of significance was at the 95 % confidence interval
and p values less than 0.05. Data was subjected to multi-
variate analysis using logistic regression model with noc-
turnal enuresis as the dependent variable and the possible
risk factors as the independent variables.
Results
Demographics
A total of 140 children were studied; 70 with SCA (Sub-
jects) and 70 with haemoglobin AA genotype (Controls).
The gender distribution showed 39 (55.7 %) males and
31 (44.3 %) females giving a male–female ratio of 1.3:1.
The mean age of the Subjects and Controls with the
same age range of 5 to 11 years was 8.37 ± 2.02 years
(8.10 ± 1.96 years for males and 8.71 ± 2.05 years for fe-
males in both cohorts). The difference in their mean
ages was not statistically significant (t = 1.78, p = 0.07).
Table 2 Prevalence of nocturnal enuresis in relation to gender
Nocturnal
enuresis
Sex OR p value 95 % C.I for
ORMale Female
Subjects (SS)
Yes 19 (48.7) 3 (9.7) 8.143 0.002 2.122–31.240
No 20 (51.3) 28 (90.3)
Total 39 (100.0) 31 (100.0)
Controls (AA)
Yes 9 (23.1) 6 (19.4) 1.161 0.801 0.363–3.713
No 30 (76.9) 25 (80.6)
Total 39 (100.0) 31 (100.0)




SEC class χ2 p value
Lower Middle Upper
Subjects (SS)
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As shown in Table 1, 23 (32.9 %) Subjects and 18
(25.7 %) Controls had enuresis although the difference
was not statistically significant [OR (95 % CI) =1.41
(0.68–2.94), x2 = 0.86, p = 0.353]. However, 22 (31.4 %)
Subjects and 15 (21.4 %) Controls had nocturnal en-
uresis. Only 1 (1.4 %) Subject and 3 (4.3 %) Controls
had day-time enuresis. Notably, the difference in the
prevalence of nocturnal enuresis in both cohorts was
not statistically significant (x2 = 1.80, p = 0.180). The
prevalence of day time enuresis was 1.4 % in Subjects
and 4.3 % in Controls.
Prevalence of nocturnal enuresis versus risk factors
Eleven (29.7 %) Subjects in early school age (5–8 years) and
11 (33.3 %) in late school age (9–11 years) had nocturnal
enuresis compared with 10 (27.0 %) and 5 (15.2 %) of the
Controls in early and late school ages respectively. The dif-
ference between the prevalence of nocturnal enuresis in
early versus late school age among the Subjects and the
Controls was not statistically significant (x2 = 0.11, p = 0.746
for Subjects and x2 = 1.46, p = 0.227 for Controls). With re-
spect to gender, 19 (48.7 %) male and 3 (9.7 %) female Sub-
jects compared with 9 (23.1 %) male and 6 (19.4 %) female
Controls had nocturnal enuresis (Table 2). Remarkably, the
prevalence of nocturnal enuresis was significantly higher in
male Subjects compared to female Subjects [OR (95 % CI)
= 8.14 (2.12– 31.24), x2 = 12.21, p < 0.001]
In Table 3, the distribution of the frequency of noctur-
nal enuresis among Subjects and Controls according to
socio-economic class shows that 21, 27 and 22 Subjects
and 15, 27 and 28 Controls belonged to the lower, mid-
dle and upper socio-economic classes (SEC) respectively.
There was no significant difference between the distribu-
tion of socio-economic classes of Subjects and Controls
(x2 = 1.72, p = 0.423). There was also no statistically sig-
nificant relationship between socio-economic status and
the prevalence of nocturnal enuresis among the Subjects
(p = 0.962) and the Controls (p = 0.986).
Furthermore, 12 (17.1 %) Subjects and 17 (24.3 %)
Controls had parents with childhood history of enuresis
but while 75 % of these 12 subjects had nocturnal enur-
esis themselves only 41.2 % of the 17 controls had noc-
turnal enuresis. Between the Subjects and the Controls,
there was no significant difference in the prevalence of
nocturnal enuresis among those with a positive historyTable 1 Prevalence of nocturnal enuresis in subjects and
controls
Nocturnal enuresis Subjects (SS) Controls (AA) χ2 p value
Yes 22 (31.4) 15 (21.4) 1.800 0.180
No 48 (68.6) 55 (78.6)
Total 70 (100.0) 70 (100.0)of enuresis in the parents (75.0 % versus 41.2 %; p = 0.071)
or among those with a negative history (22.4 % versus
15.1 %; p = 0.325). However, among the Subjects, the preva-
lence of enuresis was significantly higher in those whose
parents had a positive history of enuresis in childhood [OR
(95 % CI) =10.39 (2.45–44.05), p = 0.002] (Table 4).
In the relationship between the prevalence of nocturnal
enuresis and sibling history of enuresis in the Subjects and
the Controls, there was no significant difference in enur-
etic versus non-enuretic Subjects (x2 = 2.85, p = 0.091)
and enuretic versus non-enuretic Controls (Fisher Exact
Test, p = 0.347) (Table 5). Eleven Subjects (29.7 %) in the
early school age (5–8 years) and another 11 (33.3 %) in
the late school age (9–11 years) had nocturnal enuresis.
Ten (27.0 %) of Controls in the early school age and 5
(15.2 %) in the late school age had nocturnal enuresis
(Table 6).
Predictors of nocturnal enuresis
In Table 7, male gender [OR (95 % CI) = 20.18
(3.313–122.951), p = 0.001], age group 5–8 years [OR
(95 % CI) = 0.23 (0.056–0.967), p = 0.045], and parental
history of nocturnal enuresis [OR (95 % CI) = 20.47
(2.690–155.704), p = 0.004] were predictors of noc-
turnal enuresis in the Subjects. However, none ofYes 7 (33.3) 8 (29.6) 7 (31.8) 0.077 0.962
No 14 (66.7) 19 (70.4) 15 (68.2)
Total 21 (100.0) 27 (100.0) 22 (100.0)
Controls (AA)
Yes 3 (20.0) 6 (22.2) 6 (21.4) 0.028 0.986
No 12 (80.0) 21 (77.8) 22 (78.6)
Total 15 (100.0) 27 (100.0) 28 (100.0)
Table 4 Relationship between the prevalence of nocturnal





N n (%) N n (%) χ2/p
Yes 12 9 (75.0) 17 7 (41.2) 3.25/0.071
No 58 13 (22.4) 53 8 (15.1) 0.97/0.325
p (Fisher Exact Test) 0.002 0.060
N number studied, n (%) number (percentage) with enuresis
Table 6 Prevalence of nocturnal enuresis in relation to age
Nocturnal
enuresis
Age (years) χ2 p value
5–8 9–11
Subjects (SS)
Yes 11 (29.7) 11 (33.3) 0.105 0.746
No 26 (70.3) 22 (66.7)
Total 37 (100.0) 33 (100.0)
Controls (AA)
Yes 10 (27.0) 5 (15.2) 1.461 0.227
No 27 (73.0) 28 (84.4)
Total 37 (100.0) 33 (100.0)
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the Controls (Table 8).
Discussion
Prevalence of nocturnal enuresis
In the current study, school-aged children with SCA
showed a tendency for nocturnal enuresis more than
their non-affected class-mates with normal haemoglobin
genotype. Furthermore, the prevalence of nocturnal en-
uresis was significantly higher among the male children
with SCA than in their male controls. It was also higher
among the subjects with parental history of nocturnal
enuresis in childhood than in controls whose parents
had a similar history. In comparison, previous studies in-
dicate that children with SCA have a significantly higher
prevalence of nocturnal enuresis than those with normal
haemoglobin genotype [9–14]. For instance, the study in
South-west Nigeria reported prevalence values of 41.6 %
in children with SCA and 18.5 % in those with normal
haemoglobin [12]. Another study in North-west Nigeria
also documented a prevalence rate of 47.1 % in children
with homozygous sickle-cell disease, which was signifi-
cantly higher than that obtained in controls [13]. Simi-
larly, Jordan et al. [13] reported that life time rates of
nocturnal enuresis among children with the disease
exceeded population prevalence and sibling control
rates. Other workers noted that 35.7 % of children with
the disease met the DSM-IV criteria for nocturnal enur-
esis compared to 5 % prevalence in normal children
[14]. Elsewhere in Congo Brazzaville, other investigators
documented a prevalence of 50.9 % in SCA subjects andTable 5 Relationship between the prevalence of nocturnal






N n (%) N n (%) χ2 p
Yes 25 11 (44.0) 19 6 (31.6) 0.70 0.402
No 45 11 (24.4) 51 9 (17.6) 0.67 0.413
χ2/p 2.85/0.091 NA/0.347a
N number studied, n (%) number (percentage) with enuresis
aFisher Exact Test16.4 % in those with normal haemoglobin [9]. Interest-
ingly, the reported prevalence values in children with
SCA from these studies [9, 12–14] are higher than the
prevalence of 31.4 % in the present study.. The relatively
high prevalence figures of these previous studies may be
attributed to differences in definition of enuresis [9], and
subject selection bias [12]. Whereas the age range of the
subjects in our study was 5–11 years, the study in
South-west Nigeria used subjects aged between 2 and
20 years [12]. It is likely that some of the subjects who
might not have achieved bladder control were wrongly
labeled to have enuresis; thus accounting for its higher
prevalence. In addition, confounding factors such as dia-
betes mellitus, epilepsy and urinary tract infection which
can also cause nocturnal enuresis were not excluded in
these studies [9, 12].
Furthermore, the prevalence of nocturnal enuresis
among the controls in the current study is higher than
the values noted in previous studies [9, 12–14]. The rea-
son for the comparatively lower prevalence of nocturnal
enuresis among the controls in these studies (which en-
rolled children beyond the school-age bracket) may be
the observed decrease in the prevalence of enuresis with
age, particularly after the age of sixteen years and among
children with normal haemoglobin [9, 12, 18–20]. This
phenomenon was attributed to spontaneous improve-
ment by Murat and co-workers [19].Table 7 Multivariate analysis of predictors of nocturnal enuresis
in subjects
p value OR 95 % C.I. for OR
Lower Upper
Sex (male) 0.001 21.126 3.452 129.282
Age group (5–8 years) 0.046 0.233 0.056 0.973
Social Class (upper) 0.670 0.714 0.151 3.375
SIBNE 0.233 2.321 0.582 9.257
PNE 0.003 22.005 2.929 165.327
SIBNE Sibling nocturnal enuresis, PNE Parental nocturnal enuresis
Table 8 Multivariate analysis of predictors of nocturnal enuresis
in controls
p value OR 95 % C.I. for OR
Lower Upper
Sex (male) 0.816 0.855 0.229 3.197
Age group (5–8 years) 0.158 2.625 0.687 10.026
Social Class (upper) 0.660 1.353 0.352 5.197
SIBNE 0.107 3.016 0.787 11.553
PNE 0.018 5.216 1.327 20.503
SIBNE Sibling nocturnal enuresis, PNE Parental nocturnal enuresis
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The male predominance of nocturnal enuresis among
children with SCA noted in our study is in tandem with
the findings from other studies [10, 12, 13, 21]. A similar
trend has also been reported among children with nor-
mal haemoglobin genotype [13, 22–24]. This suggests
that factors contributing to enuresis in normal children
such as slower maturation and reduced responsiveness
to toilet training in boys [23], as well as more frequent
developmental delays [24], are equally important in chil-
dren with SCA. In contrast, other researchers have doc-
umented a female predominance in their subjects [9].
Generally, limited progress has been made in establish-
ing the etiology and pathophysiology of nocturnal enur-
esis in subjects with the disease. One author had noted
that nocturnal enuresis in children can result from an
interaction of detrusor instability, delayed arousal from
sleep and nocturnal polyuria [25]. In addition, Kawauchi
et al. [26] observed that in enuretic children, the bladder
capacity during sleep was significantly smaller than the
day-time functional capacity; underscoring the role of
the inability to hold urine during sleep as an important
cause of nocturnal enuresis. Nonetheless, in a recent re-
view by Wolf et al. [27], the postulated non-mutually ex-
clusive causes of nocturnal enuresis in subjects with
sickle-cell disease were listed as hyposthenuria leading
to nocturnal polyuria, decreased bladder capacity or
nocturnal bladder over activity, increased arousal thresh-
olds, and sleep-disordered breathing (SDB).
Another risk factor for nocturnal enuresis observed in
children with SCA in the present study is the history of
parental enuresis during childhood which contrasts with
the report in one previous study [13]. However, sibling
history of enuresis was not a significant risk factor in
our study. This finding further underscores the fact that
while genetic factors may play a role in determining the
prevalence of enuresis among parents and their off-
springs, somatic and psychosocial factors may modulate
these genetic factors in different off-springs of the same
parents [28]. The effect of these modulatory influences
is corroborated by Jordan et al. [11], who observed a
higher prevalence of nocturnal enuresis among childrenwith SCA compared to their sibling controls. Better still,
the higher prevalence of enuresis among subjects with
parental rather than sibling history of NE, in contrast to
the controls may further suggest that these somatic and
psychosocial factors have less modulatory influence on
the genetic factors in children with SCA than in non-
affected children. We observed that 75 % of the 12 SCA
children with parental history of NE had personal his-
tory of NE while only 41.2 % of the 17 controls with par-
ental history of NE had similar personal history. This
suggests that parental history of NE may play a more
significant role in children with SCA than in those with
normal haemoglobin.
The present study has also noted that socio-economic
status did not have any significant impact on the preva-
lence of nocturnal enuresis; which compares with the re-
ports by Ogunrinde et al. in Nigeria [13], Readett and
co-workers in Jamaica [21], as well as Hansakunachaj
et al. in Thailand [29]. This finding is however at vari-
ance with previous observations [22–24], which noted
that enuresis was more frequent among normal children
from the lower socio-economic class. Conversely, a
study in mid-west Nigeria reported a higher prevalence
of nocturnal enuresis among normal children from
higher socio-economic class [30]. Thus, there appears to
be no unanimity on the role of socio-economic status as
a risk factor for nocturnal enuresis among affected and
unaffected children. It may well reflect the improved
awareness of health and health-related matters across
the social classes. Readett and co-workers attributed this
finding to the relative unreliability of social amenities in
predicting social status [21].
Study limitation
The power of recall by some parents/care-givers might
have been be a source of bias in the prevalence of
nocturnal enuresis among the study cohorts. Again, this
memory lapse might have affected our evaluation of
parental history of nocturnal enuresis in childhood as a
potential socio-demographic risk factor.
Conclusions
In conclusion, children with SCA have a tendency to
develop nocturnal enuresis when compared to their
counterparts with normal haemoglobin genotype. In
addition, gender and parental history of childhood
nocturnal enuresis are potential socio-demographic risk
factors. It is hoped that the findings of this study will
provide base-line reference data for future studies in this
clime. It is recommended that school-aged children with
SCA who are in steady state should be frequently evalu-
ated for nocturnal enuresis, particularly if they are male
children and have parents with history of nocturnal
enuresis in childhood.
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